BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30380298)

  • 1. Bioconjugation of Supramolecular Metallacages to Integrin Ligands for Targeted Delivery of Cisplatin.
    Han J; Räder AFB; Reichart F; Aikman B; Wenzel MN; Woods B; Weinmüller M; Ludwig BS; Stürup S; Groothuis GMM; Permentier HP; Bischoff R; Kessler H; Horvatovich P; Casini A
    Bioconjug Chem; 2018 Nov; 29(11):3856-3865. PubMed ID: 30380298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of New Palladium Cages as Potential Delivery Systems for the Anticancer Drug Cisplatin.
    Schmidt A; Molano V; Hollering M; Pöthig A; Casini A; Kühn FE
    Chemistry; 2016 Feb; 22(7):2253-6. PubMed ID: 26756963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly luminescent metallacages featuring bispyridyl ligands functionalised with BODIPY for imaging in cancer cells.
    Woods B; Döllerer D; Aikman B; Wenzel MN; Sayers EJ; Kühn FE; Jones AT; Casini A
    J Inorg Biochem; 2019 Oct; 199():110781. PubMed ID: 31357067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly-fluorescent BODIPY-functionalised metallacages as drug delivery systems: synthesis, characterisation and cellular accumulation studies.
    Aikman B; Bonsignore R; Woods B; Doellerer D; Scotti R; Schmidt C; Heidecker AA; Pöthig A; Sayers EJ; Jones AT; Casini A
    Dalton Trans; 2022 May; 51(19):7476-7490. PubMed ID: 35470841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells.
    Wang Y; Wang X; Zhang Y; Yang S; Wang J; Zhang X; Zhang Q
    J Drug Target; 2009 Jul; 17(6):459-67. PubMed ID: 19527117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
    Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
    Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
    Wang F; Chen L; Zhang R; Chen Z; Zhu L
    J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
    Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
    J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioconjugate Supramolecular Pd
    Woods B; Silva RDM; Schmidt C; Wragg D; Cavaco M; Neves V; Ferreira VFC; Gano L; Morais TS; Mendes F; Correia JDG; Casini A
    Bioconjug Chem; 2021 Jul; 32(7):1399-1408. PubMed ID: 33440122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac.
    Sudha T; Bharali DJ; Yalcin M; Darwish NH; Coskun MD; Keating KA; Lin HY; Davis PJ; Mousa SA
    Nanomedicine (Lond); 2017 Feb; 12(3):195-205. PubMed ID: 28102776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor.
    Lee S; Kim J; Shim G; Kim S; Han SE; Kim K; Kwon IC; Choi Y; Kim YB; Kim CW; Oh YK
    J Control Release; 2012 Dec; 164(2):213-20. PubMed ID: 22664473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
    He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
    J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin.
    Falvo E; Tremante E; Fraioli R; Leonetti C; Zamparelli C; Boffi A; Morea V; Ceci P; Giacomini P
    Nanoscale; 2013 Dec; 5(24):12278-85. PubMed ID: 24150593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.
    Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G
    Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical strategies to study the formation and drug delivery capabilities of ferritin-encapsulated cisplatin in sensitive and resistant cell models.
    Turiel-Fernández D; Blanco-González E; Corte-Rodríguez M; Bettmer J; Montes-Bayón M
    Anal Bioanal Chem; 2020 Sep; 412(24):6319-6327. PubMed ID: 32185440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioconjugation strategies to couple supramolecular exo-functionalized palladium cages to peptides for biomedical applications.
    Han J; Schmidt A; Zhang T; Permentier H; Groothuis GM; Bischoff R; Kühn FE; Horvatovich P; Casini A
    Chem Commun (Camb); 2017 Jan; 53(8):1405-1408. PubMed ID: 28079225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
    He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
    Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38.
    Alibolandi M; Amel Farzad S; Mohammadi M; Abnous K; Taghdisi SM; Kalalinia F; Ramezani M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1003-1014. PubMed ID: 29806500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of cisplatin in a pegylated calcium phosphate nanoparticle (CPNP) for enhanced cytotoxicity to cancerous cells.
    Ding Y; Zhai K; Pei P; Lin Y; Ma Y; Zhu H; Shao M; Yang X; Tao W
    J Colloid Interface Sci; 2017 May; 493():181-189. PubMed ID: 28092816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization and in vivo evaluation of a magnetic cisplatin delivery nanosystem based on PMAA-graft-PEG copolymers.
    Voulgari E; Bakandritsos A; Galtsidis S; Zoumpourlis V; Burke BP; Clemente GS; Cawthorne C; Archibald SJ; Tuček J; Zbořil R; Kantarelou V; Karydas AG; Avgoustakis K
    J Control Release; 2016 Dec; 243():342-356. PubMed ID: 27793687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.